ArticleBreast cancer research and treatment2017
Recurrence risk perception and quality of life following treatment of breast cancer.
Article in Breast cancer research and treatment, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Effect of different visual presentations on the comprehension of prognostic information: a systematic review.BMC medical informatics and decision making · 2021Pooled it
- Predictors and Interdependence of Quality of Life in a Random Sample of Long-Term Young Breast Cancer Survivors and Their Biological Relatives.Cancer medicine · 2024Trial
- Consistency between recurrent risk perception and objective recurrence risk in patients after atrial fibrillation ablation: a cross-sectional study.BMC cardiovascular disorders · 2026Article
- Patient-reported duplication and missed breast cancer survivorship care more than 5 years after initial treatment.Journal of cancer survivorship : research and practice · 2026Article
- Risk perception bias, lifestyle, and chronic disease risk in the middle-aged and older Chinese population: results of a national prospective longitudinal study.BMC public health · 2026Article
- Patient perceptions around the use of clinico-pathologic and genomic tools in the management of early breast cancer.Breast cancer research and treatment · 2025Article
- Machine learning-based integration develops relapse related signature for predicting prognosis and indicating immune microenvironment infiltration in breast cancer.Scientific reports · 2025Article
- Patient-reported outcomes, and perceptions and knowledge about recurrence in women with hormone receptor-positive breast cancer.Breast cancer research and treatment · 2025Article
- Impact of an online decision support tool for ductal carcinoma in situ (DCIS) using a pre-post design (AFT-25).Breast cancer research : BCR · 2024Article
- Identification of Patients with Early HR+ HER2- Breast Cancer at High Risk of Recurrence.Geburtshilfe und Frauenheilkunde · 2024Article
- Communication with physicians and family about breast Cancer recurrence.PEC innovation · 2023Article
- Clinician and patient perspectives on screening mammography among women age 75 and older: A pilot study of a novel decision aid.PEC innovation · 2023Article
- Primary care provider attitudes about and tendency to use non-recommended surveillance tests after curative breast cancer treatment.Breast cancer research and treatment · 2023Article
- Article
- When can cancer patient treatment nonadherence be considered intentional or unintentional? A scoping review.PloS one · 2023Article
- Long term risk of distant metastasis in women with non-metastatic breast cancer and survival after metastasis detection: a population-based linked health records study.The Medical journal of Australia · 2022Article
- Relations between recurrence risk perceptions and fear of cancer recurrence in breast cancer survivors.Breast cancer research and treatment · 2022Article
- Identifying Breast Cancer Recurrence in Administrative Data: Algorithm Development and Validation.Current oncology (Toronto, Ont.) · 2022Article
- Prediction Models and Decision Aids for Women with Ductal Carcinoma In Situ: A Systematic Literature Review.Cancers · 2022Review
- Addressing the problem of overtreatment in breast cancer.Expert review of anticancer therapy · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
purposeLittle is known about different ways of assessing risk of distant recurrence following cancer treatment (e.g., numeric or descriptive). We sought to evaluate the association between overestimation of risk of distant recurrence of breast cancer and key patient-reported outcomes, including quality of life and worry.
methodsWe surveyed a weighted random sample of newly diagnosed patients with early-stage breast cancer identified through SEER registries of Los Angeles County & Georgia (2013-14) ~2 months after surgery (N = 2578, RR = 71%). Actual 10-year risk of distant recurrence after treatment was based on clinical factors for women with DCIS & low-risk invasive cancer (Stg 1A, ER+, HER2-, Gr 1-2). Women reported perceptions of their risk numerically (0-100%), with values ≥10% for DCIS & ≥20% for invasive considered overestimates. Perceptions of "moderate, high or very high" risk were considered descriptive overestimates. In our analytic sample (N = 927), we assessed factors correlated with both types of overestimation and report multivariable associations between overestimation and QoL (PROMIS physical & mental health) and frequent worry.
results30.4% of women substantially overestimated their risk of distant recurrence numerically and 14.7% descriptively. Few factors other than family history were significantly associated with either type of overestimation. Both types of overestimation were significantly associated with frequent worry, and lower QoL.
conclusionsEnsuring understanding of systemic recurrence risk, particularly among patients with favorable prognosis, is important. Better risk communication by clinicians may translate to better risk comprehension among patients and to improvements in QoL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.